GE Healthcare's MIND campaign is going online to give those affected by neurodegenerative diseases like Alzheimer's or other forms of dementia and parkinsonian syndromes a platform to share their stories.
MIND - Making an Impact on Neurodegenerative Diseases — is a global campaign initiated by GE Healthcare to identify gaps in current frameworks for the detection, diagnosis, and care of neurodegenerative disease, and to propose viable solutions. GE Healthcare is partnering with expert organizations and individuals around the world, initially focusing on France, Germany, Japan, South Korea, the United Kingdom and the United States, to drive policy to support patients, families, and caregivers affected by neurodegenerative disease, and to examine ways to reduce the cost of disease management.
Launched today, www.mindonlinecampaign.com is asking people touched by neurodegenerative disease to share their stories and inform the campaign from the grassroots.
"People who are touched by these diseases are at the core of the MIND campaign and we want to hear from them about how these diseases have affected their lives," said Pascale Witz, President and CEO, GE Healthcare, Medical Diagnostics. "We are committed to improving things for patients and for caregivers, and will use our expertise and our voice to call on policymakers to act to alleviate the suffering caused by neurodegenerative disease."
"We are looking forward to working with GE Healthcare on the MIND campaign," said Marc Wortmann, Executive Director of Alzheimer's Disease International. "Together, we will find solutions that will positively impact the lives of millions of people living with the most prevalent forms of neurodegenerative disease."